Skip to main content
Premium Trial:

Request an Annual Quote

Idaho Technology Files for FDA OK for Respiratory Panel

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Idaho Technology has filed for US Food and Drug Administration clearance of its FilmArray Respiratory Panel as an in vitro diagnostic product for patients with symptoms of upper respiratory tract infection.

The FilmArray RP is a multiplex PCR-based assay designed to detect and differentiate a panel of respiratory viruses and bacteria including adenovirus, bocavirus, corona viruses, human metapneumovirus, influenza A and B viruses, parainfluenza viruses, rhino/entero viruses, respiratory syncytial virus, Bordetella pertussis, and Mycoplasma pneumoniae.

"Several hospitals have expressed a strong interest in the FilmArray RP and many have already placed orders for it or are currently evaluating the system," Idaho Technology CEO Kirk Ririe said in a statement.

He also said that the firm expects "rapid and significant adoption" of the FilmArray RP partly because of its ability to detect and differentiate the novel influenza A H1 2009 virus.

Salt Lake City-based Idaho said that it is developing other FilmArray tests including a GI track panel, a blood culture ID panel, and an STD panel.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.